Matches in DBpedia 2015-10 for { <http://dbpedia.org/resource/Efalizumab> ?p ?o }
Showing triples 1 to 90 of
90
with 100 triples per page.
- Efalizumab abstract "Efalizumab (trade name Raptiva, Genentech, Merck Serono) is a formerly available medication designed to treat autoimmune diseases, originally marketed to treat psoriasis. As implied by the suffix -zumab, it is a recombinant humanized monoclonal antibody administered once weekly by subcutaneous injection. Efalizumab binds to the CD11a subunit of lymphocyte function-associated antigen 1 and acts as an immunosuppressant by inhibiting lymphocyte activation and cell migration out of blood vessels into tissues. Efalizumab was associated with fatal brain infections and was withdrawn from the market in 2009.Known side effects include bacterial sepsis, viral meningitis, invasive fungal disease and progressive multifocal leukoencephalopathy (PML), a brain infection caused by reactivation of latent JC virus infection. Four cases of PML were reported in plaque psoriasis patients, an incidence of approximately one in 500 treated patients.Due to the risk of PML, the European Medicines Agency and the FDA recommended suspension from the market in the European Union and the United States, respectively. In April 2009, Genentech Inc. announced a phased voluntary withdrawal of Raptiva from the U.S. market.".
- Efalizumab atcPrefix "L04".
- Efalizumab atcSuffix "AA21".
- Efalizumab casNumber "214745-43-4".
- Efalizumab drugbank "DB00095".
- Efalizumab fdaUniiCode "XX2MN88N5D".
- Efalizumab wikiPageID "5310787".
- Efalizumab wikiPageLength "4220".
- Efalizumab wikiPageOutDegree "23".
- Efalizumab wikiPageRevisionID "678179891".
- Efalizumab wikiPageWikiLink CD11a.
- Efalizumab wikiPageWikiLink Category:Immunosuppressants.
- Efalizumab wikiPageWikiLink Category:Recombinant_proteins.
- Efalizumab wikiPageWikiLink Category:Withdrawn_drugs.
- Efalizumab wikiPageWikiLink European_Medicines_Agency.
- Efalizumab wikiPageWikiLink European_Union.
- Efalizumab wikiPageWikiLink Food_and_Drug_Administration.
- Efalizumab wikiPageWikiLink Genentech.
- Efalizumab wikiPageWikiLink Humanized_antibody.
- Efalizumab wikiPageWikiLink Immunosuppressant.
- Efalizumab wikiPageWikiLink Immunosuppression.
- Efalizumab wikiPageWikiLink JC_virus.
- Efalizumab wikiPageWikiLink Lymphocyte_function-associated_antigen_1.
- Efalizumab wikiPageWikiLink Medication.
- Efalizumab wikiPageWikiLink Meningitis.
- Efalizumab wikiPageWikiLink Merck_Serono.
- Efalizumab wikiPageWikiLink Monoclonal_antibody.
- Efalizumab wikiPageWikiLink Nomenclature_of_monoclonal_antibodies.
- Efalizumab wikiPageWikiLink Pharmaceutical_drug.
- Efalizumab wikiPageWikiLink Progressive_multifocal_leukoencephalopathy.
- Efalizumab wikiPageWikiLink Psoriasis.
- Efalizumab wikiPageWikiLink Recombinant_DNA.
- Efalizumab wikiPageWikiLink Sepsis.
- Efalizumab wikiPageWikiLink Subcutaneous_injection.
- Efalizumab wikiPageWikiLinkText "Efalizumab".
- Efalizumab wikiPageWikiLinkText "Raptiva".
- Efalizumab wikiPageWikiLinkText "efalizumab".
- Efalizumab atcPrefix "L04".
- Efalizumab atcSuffix "AA21".
- Efalizumab casNumber "214745".
- Efalizumab chembl "1201575".
- Efalizumab chemspiderid "NA".
- Efalizumab drugbank "DB00095".
- Efalizumab hasPhotoCollection Efalizumab.
- Efalizumab mabType "mab".
- Efalizumab meltingPoint "66".
- Efalizumab routesOfAdministration "subcutaneous injection".
- Efalizumab source "zu/o".
- Efalizumab target CD11a.
- Efalizumab tradename "Raptiva".
- Efalizumab type "mab".
- Efalizumab unii "XX2MN88N5D".
- Efalizumab verifiedfields "changed".
- Efalizumab verifiedrevid "461092863".
- Efalizumab wikiPageUsesTemplate Template:Antineoplastic-drug-stub.
- Efalizumab wikiPageUsesTemplate Template:Drugbox.
- Efalizumab wikiPageUsesTemplate Template:Immunosuppressants.
- Efalizumab wikiPageUsesTemplate Template:Monoclonal-antibody-stub.
- Efalizumab wikiPageUsesTemplate Template:Monoclonals_for_immune_system.
- Efalizumab wikiPageUsesTemplate Template:Reflist.
- Efalizumab subject Category:Immunosuppressants.
- Efalizumab subject Category:Recombinant_proteins.
- Efalizumab subject Category:Withdrawn_drugs.
- Efalizumab type Article.
- Efalizumab type ChemicalSubstance.
- Efalizumab type Drug.
- Efalizumab type Antibody.
- Efalizumab type Article.
- Efalizumab type Chemical.
- Efalizumab type Drug.
- Efalizumab type Immunosuppressant.
- Efalizumab type Product.
- Efalizumab type ChemicalObject.
- Efalizumab type Thing.
- Efalizumab type Q8386.
- Efalizumab comment "Efalizumab (trade name Raptiva, Genentech, Merck Serono) is a formerly available medication designed to treat autoimmune diseases, originally marketed to treat psoriasis. As implied by the suffix -zumab, it is a recombinant humanized monoclonal antibody administered once weekly by subcutaneous injection.".
- Efalizumab label "Efalizumab".
- Efalizumab sameAs إيفاليزوماب.
- Efalizumab sameAs Efalizumab.
- Efalizumab sameAs Efalizumab.
- Efalizumab sameAs Efalizumab.
- Efalizumab sameAs Efalizumab.
- Efalizumab sameAs m.0ddw7w.
- Efalizumab sameAs Efalizumab.
- Efalizumab sameAs Efalizumab.
- Efalizumab sameAs Q418270.
- Efalizumab sameAs Q418270.
- Efalizumab sameAs 依法利珠单抗.
- Efalizumab wasDerivedFrom Efalizumab?oldid=678179891.
- Efalizumab isPrimaryTopicOf Efalizumab.